P3 Health Ownership
| PIII Stock | USD 5.80 1.20 17.14% |
Shares in Circulation | First Issued 2020-03-31 | Previous Quarter 3.3 M | Current Value 3.3 M | Avarage Shares Outstanding 9.7 M | Quarterly Volatility 16.4 M |
PIII Stock Ownership Analysis
About 62.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.36. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. P3 Health Partners recorded a loss per share of 52.42. The entity had not issued any dividends in recent years. The firm had 1:50 split on the 14th of April 2025. P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. P3 Health operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 523 people. To find out more about P3 Health Partners contact FACEP FACP at 702 910 3950 or learn more at https://p3hp.org.PIII Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as P3 Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading P3 Health Partners backward and forwards among themselves. P3 Health's institutional investor refers to the entity that pools money to purchase P3 Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Moneta Group Investment Advisors Inc | 2024-12-31 | 112.8 K | State Street Corp | 2024-12-31 | 101.4 K | Northern Trust Corp | 2024-12-31 | 100 K | Welch Capital Partners Llc | 2025-03-31 | 90 K | Hrt Financial Llc | 2024-12-31 | 71.3 K | Pnc Financial Services Group Inc | 2024-12-31 | 68.7 K | Point72 Asia (singapore) Pte. Ltd | 2024-12-31 | 33.2 K | Engineers Gate Manager Lp | 2024-12-31 | 28.9 K | Slatestone Wealth, Llc | 2024-12-31 | 28.4 K | Alyeska Investment Group, L.p. | 2024-12-31 | 11.9 M | Vanguard Group Inc | 2024-12-31 | 1.8 M |
P3 Health Partners Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific P3 Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on P3 Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases P3 Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
P3 Health Outstanding Bonds
P3 Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. P3 Health Partners uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PIII bonds can be classified according to their maturity, which is the date when P3 Health Partners has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ES 515 15 JAN 53 Corp BondUS744482BP42 | View | |
| PUBLIC SVC O Corp BondUS744448CN95 | View | |
| PUBLIC SVC O Corp BondUS744448CP44 | View | |
| PUBLIC SVC O Corp BondUS744448CQ27 | View | |
| US744448CR00 Corp BondUS744448CR00 | View | |
| US744448CS82 Corp BondUS744448CS82 | View | |
| US744448CT65 Corp BondUS744448CT65 | View | |
| PUBLIC SERVICE PANY Corp BondUS744448CV12 | View |
P3 Health Corporate Filings
8K | 9th of July 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 6th of June 2025 Other Reports | ViewVerify | |
| 29th of April 2025 Other Reports | ViewVerify | |
| 18th of April 2025 Other Reports | ViewVerify |
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (52.42) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.